G Covi

844 total citations
32 papers, 672 citations indexed

About

G Covi is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, G Covi has authored 32 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in G Covi's work include Hormonal Regulation and Hypertension (5 papers), Pregnancy and preeclampsia studies (4 papers) and Cardiovascular Function and Risk Factors (4 papers). G Covi is often cited by papers focused on Hormonal Regulation and Hypertension (5 papers), Pregnancy and preeclampsia studies (4 papers) and Cardiovascular Function and Risk Factors (4 papers). G Covi collaborates with scholars based in Italy and France. G Covi's co-authors include Alessandro Lechi, Guido Arcaro, C Lechi, F Armellini, Luigi Rossi, E Turcato, Mauro Zamboni, Ottavio Bosello, P Pancera and Enrico Arosio and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Hypertension and International Journal of Obesity.

In The Last Decade

G Covi

31 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Covi Italy 12 335 148 119 85 80 32 672
Tsuneharu Baba Japan 18 265 0.8× 141 1.0× 358 3.0× 133 1.6× 95 1.2× 40 824
Melissa B. Bryant United States 9 415 1.2× 406 2.7× 113 0.9× 87 1.0× 54 0.7× 11 835
Inger Sihm Denmark 12 363 1.1× 148 1.0× 164 1.4× 86 1.0× 144 1.8× 21 739
K Glänzer Germany 17 264 0.8× 88 0.6× 126 1.1× 152 1.8× 130 1.6× 43 774
G Viganò Italy 12 159 0.5× 72 0.5× 43 0.4× 62 0.7× 151 1.9× 25 635
Marco Miclini Italy 8 478 1.4× 113 0.8× 147 1.2× 45 0.5× 124 1.6× 9 705
Margrethe Mau Pedersen Denmark 17 400 1.2× 81 0.5× 318 2.7× 40 0.5× 92 1.1× 25 833
N Lasker United States 18 141 0.4× 100 0.7× 113 0.9× 203 2.4× 84 1.1× 39 700
Shigeru Yagi Japan 15 387 1.2× 252 1.7× 127 1.1× 111 1.3× 77 1.0× 65 715
B R Dunn United States 5 587 1.8× 137 0.9× 374 3.1× 194 2.3× 94 1.2× 6 1.2k

Countries citing papers authored by G Covi

Since Specialization
Citations

This map shows the geographic impact of G Covi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Covi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Covi more than expected).

Fields of papers citing papers by G Covi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Covi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Covi. The network helps show where G Covi may publish in the future.

Co-authorship network of co-authors of G Covi

This figure shows the co-authorship network connecting the top 25 collaborators of G Covi. A scholar is included among the top collaborators of G Covi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Covi. G Covi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Covi, G, P Pancera, Silvia Babighian, et al.. (2003). Autonomic System Activity and 24-Hour Blood Pressure Variations in Subjects with Normal- and High-Tension Glaucoma. Journal of Glaucoma. 12(2). 156–163. 61 indexed citations
2.
Arcaro, Guido, Mauro Zamboni, Luigi Rossi, et al.. (1999). Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity. International Journal of Obesity. 23(9). 936–942. 211 indexed citations
3.
Pancera, P, et al.. (1999). Effect of losartan on heart rate and blood pressure variability during tilt test and trinitroglycerine vasodilation. Journal of Hypertension. 17(4). 513–521. 21 indexed citations
4.
Pancera, P, et al.. (1997). The effects of thromboxane A2 inhibition (Picotamide) and angiotensin II receptor blockade (Losartan) in primary Raynaud's phenomenon. Journal of Internal Medicine. 242(5). 373–376. 30 indexed citations
5.
Covi, G, et al.. (1996). Left ventricular diastolic function during adrenergic stress in essential hypertension: acute and chronic effects of ACE inhibition. Cardiovascular Drugs and Therapy. 10(3). 321–329. 7 indexed citations
6.
Arcaro, Guido, et al.. (1995). Non-invasive detection of early endothelial dysfunction in hypercholesterolaemic subjects. Atherosclerosis. 114(2). 247–254. 46 indexed citations
7.
Artur, Yves, et al.. (1994). [Updating of relative data on tocopherols in clinical biochemistry].. PubMed. 52(1). 9–31. 2 indexed citations
8.
Covi, G, et al.. (1994). Systemic and Uteroplacental Hemodynamics and the Prostaglandin System in Pregnancy-Induced Hypertension and Normal Pregnancy. Hypertension in Pregnancy. 13(3). 273–283. 1 indexed citations
9.
Covi, G, et al.. (1992). Left ventricular diastolic function and responses to adrenergic stimuli in borderline arterial hypertension. Journal of Hypertension. 10(3). 237–243. 3 indexed citations
10.
Fruzzetti, Franca, Gian Benedetto Melis, Loris De Cecco, et al.. (1991). The use of 16,16-dimethyl-trans-Δ2prostaglandin E1methyl ester vaginal suppositories for management of missed abortion and fetal death. International Journal of Gynecology & Obstetrics. 36(2). 115–119. 1 indexed citations
11.
Sheiban, Imad, et al.. (1990). Early regression of left ventricular diastolic abnormalities in hypertensive patients treated with nifedipine. Cardiovascular Drugs and Therapy. 4(S5). 957–961. 6 indexed citations
12.
Delva, Pietro, et al.. (1989). High plasma levels of a ouabain‐like factor in normal pregnancy and in pre‐eclampsia*. European Journal of Clinical Investigation. 19(1). 95–100. 24 indexed citations
13.
Minuz, Pietro, et al.. (1987). Reduced Excretion of Vasodilator Prostaglandins in Preeclampsia. Birkhäuser Basel eBooks. 22. 175–181. 8 indexed citations
14.
Sheiban, Imad, et al.. (1987). Regression of Cardiac Hypertrophy after Antihypertensive Therapy with Nifedipine and Captopril. Journal of Cardiovascular Pharmacology. 10. S187–191. 18 indexed citations
15.
Lechi, Alessandro, C Lechi, Giovanni Bonadonna, et al.. (1987). Increased basal and thrombin-induced free calcium in platelets of essential hypertensive patients.. Hypertension. 9(3). 230–235. 64 indexed citations
16.
Covi, G, et al.. (1984). Reduction of the antihypertensive effect of captopril induced by prostaglandin synthetase inhibition.. PubMed. 4(1). 47–52. 8 indexed citations
17.
Lechi, Alessandro, Franco Mantero, Giuseppe Opocher, et al.. (1981). Effect of indomethacin on urinary kallikrein excretion in Bartter’s syndrome of the adult. Journal of Endocrinological Investigation. 4(1). 17–20. 1 indexed citations
18.
Lechi, Alessandro, et al.. (1979). An Evaluation of Tienilic Acid, a New Diuretic Uricosuric Agent, in the Therapy of Arterial Hypertension. Clinical Science. 57(s5). 367s–369s.
19.
Lechi, Alessandro, G Covi, C Lechi, et al.. (1978). Urinary Kallikrein Excretion and Plasma Renin Activity in Patients with Essential Hypertension and Primary Aldosteronism. Clinical Science. 55(1). 51–55. 42 indexed citations
20.
Lechi, C, et al.. (1976). Urinary and kidney kallikrein in hypertensive rats.. PubMed. 25(7). 236–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026